The purpose of this work is to analyze the process of importation, that is a part of the sanitary control of psychotropic substances, made by B'/> The different point of view about the sanitary control of importation of psychotropic substances in Brazil
首页> 外文期刊>Ciencia e Saude Coletiva >The different point of view about the sanitary control of importation of psychotropic substances in Brazil
【24h】

The different point of view about the sanitary control of importation of psychotropic substances in Brazil

机译:巴西精神药物进口卫生控制的不同观点

获取原文
       

摘要

> size="2" face="Verdana, Arial, Helvetica, sans-serif">The purpose of this work is to analyze the process of importation, that is a part of the sanitary control of psychotropic substances, made by Brazilian National Health Surveillance Agency's ports, airports and borders. For this work, psychotropic substances are defined as active pharmaceutical raw materials present in the list B1 of Portaria no 344/98; which need Anvisa's permission to be imported. For this purpose we used semistructured interviews with key informers and participant observation. The information were collected and systematized through the content analysis, thematic modality. The results show a very complex control which involves an intense bureaucratic process. The main identified critical points of the process were: the information system precariousness; the absence of human resources; deficiency of laboratorial support and infra-structure at customs. Anvisa's web page and the specific law are strong points of the process, but still needing improvements. We understood that despite of the progress made, there are many things to do for giving the country an efficient health control system to the importation of these substances.
机译:> size =“2”面部=“Verdana,Arial,Helvetica,Sans-Serif”>本作的目的是分析进口过程,这是精神药物卫生控制的一部分,使巴西国家卫生监测机构的港口,机场和边界。对于这项工作,精神药物被定义为Portaria的Portaria列表B1中的活性药物原料;这需要anvisa的进口许可。为此目的,我们使用与关键信息者和参与者观察的半系统面试。通过内容分析,主题方式收集并系统化信息。结果表明了一个非常复杂的控制,涉及激烈的官僚主义过程。主要确定的过程的关键点是:信息系统的不良性;没有人力资源;海关缺乏实验室支持和红外线结构。 ANVISA的网页和特定法律是进程的强项,但仍然需要改进。我们明白,尽管取得了进展,但为将国家提供了有效的健康控制系统进入这些物质有很多东西。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号